Short answer
Nuvectis Pharma, Inc. (NVCT) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Annual meeting quorum established with 16,193,686 shares represented, equal to 60.8% of shares outstanding.
Nuvectis Pharma, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Annual meeting quorum established with 16,193,686 shares represented, equal to 60.8% of shares outstanding
- Record-date share count corrected to 26,614,628 from 27,668,036, without affecting vote validity or outcomes
- Ron Bentsur reelected Class I director through the 2029 annual meeting with 8,354,838 votes for
- Kesselman & Kesselman ratified as independent auditor for fiscal 2026 with 15,662,222 votes for
- All proposals approved, preserving board leadership and auditor appointment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nuvectis Pharma, Inc. 8-K filings
Get the next NVCT 8-K as it lands
Follow NVCT for push alerts, or ask the research agent what this filing means.